Fiji Airways’ new route will connect travellers with an additional 247 destinations through one of the busiest travel hubs in the world. NADI, Fiji, Aug. 7, 2024 /PRNewswire/ — Fiji Airways has announced the first ever non-stop flights between Nadi, Fiji, and one of the busiest travel hubs in the world, Dallas Fort Worth International Airport […]
Category Archives: Pr Newswire
SYDNEY, Aug. 6, 2024 /PRNewswire/ — Nuren Group, a premier digital platform committed to empowering women in parenting, education, and maternity wellness, has officially launched its initial public offering (IPO) on the National Stock Exchange of Australia (NSX). Priced at AUD0.20 per share, this IPO marks a significant milestone in the company’s growth trajectory and […]
AI-driven Attack Signal Intelligence provides SOC teams a holistic view of their active posture and any active attacks across networks, identities, clouds and GenAI tools SINGAPORE, Aug. 7, 2024 /PRNewswire/ — Vectra AI, Inc., the leader in AI-driven XDR (extended detection and response), today announced the expansion of its Vectra AI Platform, which now equips […]
BRISBANE, Australia, Aug. 6, 2024 /PRNewswire/ — A survey of more than 1,000 Australian car owners by insurance provider Budget Direct found three-quarters of respondents (75%) believe that car technology can be distracting. The most distracting car technologies included touchscreens, hands-free mobile phones and speech-to-text systems. Of bigger concern is that over 1 in 10 (16%) reported […]
Growing Cloud Complexity Spurs Demand for Comprehensive Security Solutions SAN ANTONIO, Aug. 7, 2024 /PRNewswire/ — As businesses increasingly migrate to the cloud and adopt cloud-native technologies, the complexity and attack surface of their digital environments have expanded dramatically. Recognising the critical need to secure these environments, organisations are turning to Cloud Security Posture Management (CSPM) […]
Pr Newswire
TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
06
Aug
Aug
Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at ~20% of the oral tacrolimus dose prevented acute rejection and achieved >80% of the previous oral trough blood levels — leading to diminished drug burden 9 out of 9 (100%) patients who completed the 12-week treatment chose to remain on TFF […]
06
Aug
Aug
CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will provide business updates and report its financial results for the second quarter ended […]
06
Aug
Aug
MALVERN, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced new preclinical data demonstrating the synergistic effect of its lead compound, buntanetap, […]
06
Aug
Aug
19,000-square-foot facility reflects the company’s recent growth and continued commitment to the region MORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) — Science 37, a leader in enhancing patient access to clinical trials, today announced the grand opening of its new, 19,000-square-foot corporate headquarters in Morrisville, North Carolina, in the heart of Research Triangle Park. The […]
Pr Newswire
Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
06
Aug
Aug
Clinical update presented at ASCO 2024 for CRB-701 showed continued differentiated safety and encouraging efficacy in patients with metastatic urothelial cancer or cervical cancer CRB-701 Phase 1 dose escalation underway in USA and Europe for patients with metastatic urothelial cancer and other nectin-4 enriched tumors and is on schedule for completion in Q4 2024 Cash […]